Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2587-00-0

Post Buying Request

2587-00-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2587-00-0 Usage

Chemical Properties

Orange-Yellow Crystals

Uses

2,6-Dichloropyridine-1-oxide (cas# 2587-00-0) is a compound useful in organic synthesis.

Check Digit Verification of cas no

The CAS Registry Mumber 2587-00-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,5,8 and 7 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 2587-00:
(6*2)+(5*5)+(4*8)+(3*7)+(2*0)+(1*0)=90
90 % 10 = 0
So 2587-00-0 is a valid CAS Registry Number.
InChI:InChI=1/C5H4Cl2NO/c6-4-2-1-3-5(7)8(4)9/h1-4H/q+1

2587-00-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (D3219)  2,6-Dichloropyridine N-Oxide  >98.0%(GC)

  • 2587-00-0

  • 5g

  • 745.00CNY

  • Detail
  • Alfa Aesar

  • (H30427)  2,6-Dichloropyridine N-oxide, 98%   

  • 2587-00-0

  • 1g

  • 248.0CNY

  • Detail
  • Alfa Aesar

  • (H30427)  2,6-Dichloropyridine N-oxide, 98%   

  • 2587-00-0

  • 5g

  • 851.0CNY

  • Detail
  • Aldrich

  • (594059)  2,6-DichloropyridineN-oxide  98%

  • 2587-00-0

  • 594059-5G

  • 1,151.28CNY

  • Detail

2587-00-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,6-dichloro-1-oxidopyridin-1-ium

1.2 Other means of identification

Product number -
Other names 2,6-Dichloropyridine 1-oxide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2587-00-0 SDS

2587-00-0Synthetic route

2,6-dichloropyridine
2402-78-0

2,6-dichloropyridine

2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

Conditions
ConditionsYield
With dihydrogen peroxide; trifluoroacetic acid at 80℃; for 2h; Reagent/catalyst; Temperature;90.15%
With dihydrogen peroxide; trifluoroacetic acid In water at 0℃; for 6.5h; Reflux;87.6%
With dihydrogen peroxide; trifluoroacetic acid In water for 6.5h; Reflux;87.6%
2,6-dichloropyridine
2402-78-0

2,6-dichloropyridine

dihydrogen peroxide
7722-84-1

dihydrogen peroxide

2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

Conditions
ConditionsYield
With trifluoroacetic acid
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

2,6-dichloropyridine
2402-78-0

2,6-dichloropyridine

Conditions
ConditionsYield
With 2-methyl-but-2-ene; trans-dioxo(5,10,15,20-tetramesitylporphirinato)ruthenium(VI) In benzene at 30℃; for 15h;94%
With (4,4′-di-tert-butyl-2,2′-bipyridine)bis[(2-pyridinyl)phenyl]iridium(III) hexafluorophosphate; di-tert-butyl 1,4-dihydro-2,6-dimethyl-3,5-pyridine-dicarboxylate In acetonitrile at 20℃; for 0.75h; Inert atmosphere; Irradiation; chemoselective reaction;92%
With ammonium formate; silica gel; zinc In methanol at 20℃; for 0.166667h; chemoselective reaction;88%
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

octanol
111-87-5

octanol

1-hydroxy-6-(octyloxy)pyridine-2(1H)-one
162912-64-3

1-hydroxy-6-(octyloxy)pyridine-2(1H)-one

Conditions
ConditionsYield
With sodium hydroxide In water at 20 - 120℃; pH=3.5 - 4.0; Reflux;90.6%
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

2,4,6-trichloropyridine
16063-69-7

2,4,6-trichloropyridine

Conditions
ConditionsYield
With trichlorophosphate for 4h; Reflux;85%
With trichlorophosphate for 4h; Reflux;85%
With trichlorophosphate for 4h; Reflux;85%
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

C5H4BCl2NO3
1415388-29-2

C5H4BCl2NO3

Conditions
ConditionsYield
With (1,5-cyclooctadiene)(methoxy)iridium(I) dimer; bis(pinacol)diborane; 4,4'-di-tert-butyl-2,2'-bipyridine85%
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

allyl (4-bromophenyl)sulfide
6334-55-0

allyl (4-bromophenyl)sulfide

phenylacetylene
536-74-3

phenylacetylene

2-(4-bromophenylthio)-1-phenylpent-4-en-1-one

2-(4-bromophenylthio)-1-phenylpent-4-en-1-one

Conditions
ConditionsYield
With Mor-DaIPhos-AuCl; sodium tetrakis[(3,5-di-trifluoromethyl)phenyl]borate In 1,2-dichloro-ethane at 60℃; for 20h;77%
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

A

2-chloropyridine
109-09-1

2-chloropyridine

B

2,6-dichloropyridine
2402-78-0

2,6-dichloropyridine

Conditions
ConditionsYield
With copper(l) iodide; zinc In ethanol at 55 - 60℃; for 3h;A n/a
B 75%
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

[(N,N’-bis(2,6-diisopropylphenyl)imidazol-2-ylidene)Ge{CH(SiMe3)2}][(3,5-(CF3)2C6H3)4]

[(N,N’-bis(2,6-diisopropylphenyl)imidazol-2-ylidene)Ge{CH(SiMe3)2}][(3,5-(CF3)2C6H3)4]

C32H12BF24(1-)*C39H58Cl2GeN3O2Si2(1+)

C32H12BF24(1-)*C39H58Cl2GeN3O2Si2(1+)

Conditions
ConditionsYield
In fluorobenzene at 20℃; for 0.0833333h; Inert atmosphere;73%
1-allylsulfanyl-4-chloro-benzene
15446-14-7

1-allylsulfanyl-4-chloro-benzene

2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

phenylacetylene
536-74-3

phenylacetylene

2-(4-chlorophenylthio)-1-phenylpent-4-en-1-one

2-(4-chlorophenylthio)-1-phenylpent-4-en-1-one

Conditions
ConditionsYield
With Mor-DaIPhos-AuCl; sodium tetrakis[(3,5-di-trifluoromethyl)phenyl]borate In 1,2-dichloro-ethane at 60℃; for 8h;70%
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

2,6-dichloro-4-nitro-pyridine
25194-01-8

2,6-dichloro-4-nitro-pyridine

Conditions
ConditionsYield
Stage #1: 2,6-dichloropyridine N-oxide With sulfuric acid; nitric acid In water at 148 - 156℃; for 1h;
Stage #2: With ammonia In water pH=6;
66.4%
Stage #1: 2,6-dichloropyridine N-oxide With sulfuric acid; nitric acid at 148 - 156℃; for 1h;
Stage #2: With ammonia In water at 20℃; pH=6;
66.4%
With sulfuric acid; nitric acid for 15h; Heating;25%
With sulfuric acid; nitric acid at 160℃;
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

2-amino-6-chloropyridine N-oxide

2-amino-6-chloropyridine N-oxide

Conditions
ConditionsYield
With ammonia In methanol at 105℃; for 26h;55%
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

2-ethyl-7-mercapto-8-methyl-4H-chromen-4-one
1362586-97-7

2-ethyl-7-mercapto-8-methyl-4H-chromen-4-one

7-(6-chloropyridin-2-ylthio)-2-ethyl-8-methyl-4H-chromen-4-one N-oxide
1362586-28-4

7-(6-chloropyridin-2-ylthio)-2-ethyl-8-methyl-4H-chromen-4-one N-oxide

Conditions
ConditionsYield
With pyridine at 20℃; for 2h;53%
With pyridine for 2h; Reflux;53%
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

2-ethyl-7-mercapto-4H-chromen-4-one
1337971-33-1

2-ethyl-7-mercapto-4H-chromen-4-one

7-(6-chloropyridin-2-ylthio)-2-ethyl-4H-chromen-4-one N-oxide
1362586-25-1

7-(6-chloropyridin-2-ylthio)-2-ethyl-4H-chromen-4-one N-oxide

Conditions
ConditionsYield
With pyridine at 20℃; for 2h;51%
2-(trifluoromethoxy)biphenylyl-2'-diazonium hexafluoroantimonate

2-(trifluoromethoxy)biphenylyl-2'-diazonium hexafluoroantimonate

2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

N-trifluoromethoxy-2,6-dichloropyridinium hexafluoroantimonate

N-trifluoromethoxy-2,6-dichloropyridinium hexafluoroantimonate

Conditions
ConditionsYield
In dichloromethane at 42℃; for 3.5h; Sealed tube; Inert atmosphere;51%
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

7-mercapto-4-methyl-2H-chromen-2-one
137215-27-1

7-mercapto-4-methyl-2H-chromen-2-one

7-(6-chloropyridin-2-ylthio)-4-methyl-2H-chromen-2-one N-oxide
1141172-55-5

7-(6-chloropyridin-2-ylthio)-4-methyl-2H-chromen-2-one N-oxide

Conditions
ConditionsYield
With pyridine at 20℃; for 2h;48%
With pyridine for 2h; Reflux;48%
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

tert-butylmagnesium chloride
677-22-5

tert-butylmagnesium chloride

2-(tert-butyl)-6-chloropyridine 1-oxide

2-(tert-butyl)-6-chloropyridine 1-oxide

Conditions
ConditionsYield
With copper(l) iodide In tetrahydrofuran at 0 - 20℃; Inert atmosphere;45%
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

2-Chloropyridinyl 6-disulfide
72917-33-0

2-Chloropyridinyl 6-disulfide

Conditions
ConditionsYield
With thiourea In ethanol for 2h; Heating;40%
Togni's reagent
887144-97-0

Togni's reagent

2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

trimethylsilyl bis(trifluoromethanesulfonyl)imide
82113-66-4

trimethylsilyl bis(trifluoromethanesulfonyl)imide

2,6-dichloro-N-(trifluoromethoxy)pyridinium triflimide

2,6-dichloro-N-(trifluoromethoxy)pyridinium triflimide

Conditions
ConditionsYield
Stage #1: 2,6-dichloropyridine N-oxide; trimethylsilyl bis(trifluoromethanesulfonyl)imide In dichloromethane at 20℃; Schlenk technique; Inert atmosphere; Glovebox;
Stage #2: Togni's reagent In dichloromethane at 20℃; for 12h; Schlenk technique; Inert atmosphere; Glovebox;
39%
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

2-hydroxylamino-6-chloropyridine 1-oxide
72647-13-3

2-hydroxylamino-6-chloropyridine 1-oxide

Conditions
ConditionsYield
With hydroxylamine In ethanol for 144h; Ambient temperature;24%
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

C32H50FeN4
1433221-40-9

C32H50FeN4

C64H100Fe2N8O
1433221-44-3

C64H100Fe2N8O

Conditions
ConditionsYield
In benzene at -78 - 20℃; for 8h; Inert atmosphere;18%
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

isopropylamine
75-31-0

isopropylamine

(6-chloro-1-oxy-pyridin-2-yl)-isopropyl-amine
59618-29-0

(6-chloro-1-oxy-pyridin-2-yl)-isopropyl-amine

Conditions
ConditionsYield
In hexane; dimethyl sulfoxide15.01%
piperidine
110-89-4

piperidine

2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

6'-chloro-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl 1'-oxide
59618-35-8

6'-chloro-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl 1'-oxide

Conditions
ConditionsYield
In hexane; benzene12.9%
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

3-Chlorostyrene
2039-85-2

3-Chlorostyrene

A

2,6-dichloropyridine
2402-78-0

2,6-dichloropyridine

B

(R)-meta-chlorostyrene oxide
20697-04-5, 53631-04-2, 115648-90-3, 62600-71-9

(R)-meta-chlorostyrene oxide

C

(S)-3-chlorostyrene oxide
115648-90-3

(S)-3-chlorostyrene oxide

Conditions
ConditionsYield
chiral ruthenium porphyrin complex catalyst In toluene at -10℃; for 48h; Title compound not separated from byproducts.;
4-vinylbenzyl chloride
1073-67-2

4-vinylbenzyl chloride

2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

A

2,6-dichloropyridine
2402-78-0

2,6-dichloropyridine

B

(R)-2-(4-chlorophenyl)oxirane
2788-86-5, 53649-47-1, 97466-49-4, 21019-51-2

(R)-2-(4-chlorophenyl)oxirane

C

(2S)-2-(4-chlorophenyl)oxirane
2788-86-5, 21019-51-2, 53649-47-1, 97466-49-4

(2S)-2-(4-chlorophenyl)oxirane

Conditions
ConditionsYield
chiral ruthenium porphyrin complex catalyst In toluene at -10℃; for 48h; Title compound not separated from byproducts.;
1-propenylbenzene
873-66-5

1-propenylbenzene

2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

A

2,6-dichloropyridine
2402-78-0

2,6-dichloropyridine

B

(1S,2S)-(-)-1-phenyl-1-propene oxide
4518-66-5

(1S,2S)-(-)-1-phenyl-1-propene oxide

C

(+)-(R,R)-β-methylstyrene oxide
14212-54-5

(+)-(R,R)-β-methylstyrene oxide

Conditions
ConditionsYield
chiral ruthenium porphyrin complex catalyst In toluene at -10℃; for 48h; Title compound not separated from byproducts.;
styrene
292638-84-7

styrene

2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

A

2,6-dichloropyridine
2402-78-0

2,6-dichloropyridine

B

(R)-Styrene oxide
20780-53-4

(R)-Styrene oxide

C

(S)-styrene oxide
20780-54-5

(S)-styrene oxide

Conditions
ConditionsYield
chiral ruthenium porphyrin complex catalyst In toluene at -10℃; for 48h; Title compound not separated from byproducts.;
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

8-chloro-3-deazaadenine

8-chloro-3-deazaadenine

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1: HNO3; H2SO4 / 160 °C
2: AcOH; Fe / Heating
3: HNO3; H2SO4 / 20 °C
4: H2SO4 / 100 °C
5: 51 percent / Fe / 2 h / Heating
6: aq. NaOH / Heating
7: 96 percent / Ac2O / 4.5 h / Heating
8: 49 percent / ammonia / methanol / 90 h / 160 °C
9: 72 percent / NaOH; H2 / Pd/C / H2O / 20 h / 1758.3 Torr
10: 31 percent / t-butyl hypochlorite / dimethylsulfoxide / 144 h / 20 °C
View Scheme
Multi-step reaction with 10 steps
1: HNO3; H2SO4 / 160 °C
2: AcOH; Fe / Heating
3: HNO3; H2SO4 / 20 °C
4: H2SO4 / 100 °C
5: 51 percent / Fe / 2 h / Heating
6: aq. NaOH / Heating
7: 96 percent / Ac2O / 4.5 h / Heating
8: 49 percent / ammonia / methanol / 90 h / 160 °C
9: 72 percent / NaOH; H2 / Pd/C / H2O / 20 h / 1758.3 Torr
10: HCl; mCPBA / N,N-dimethyl-acetamide / 0.42 h / 20 °C
View Scheme
Multi-step reaction with 9 steps
1: HNO3; H2SO4 / 160 °C
2: AcOH; Fe / Heating
3: HNO3; H2SO4 / 20 °C
4: H2SO4 / 100 °C
5: 94 percent / Fe; H2O; HCl / ethanol / 16 h / 95 °C
6: 96 percent / Ac2O / 4.5 h / Heating
7: 49 percent / ammonia / methanol / 90 h / 160 °C
8: 72 percent / NaOH; H2 / Pd/C / H2O / 20 h / 1758.3 Torr
9: 31 percent / t-butyl hypochlorite / dimethylsulfoxide / 144 h / 20 °C
View Scheme
Multi-step reaction with 9 steps
1: HNO3; H2SO4 / 160 °C
2: AcOH; Fe / Heating
3: HNO3; H2SO4 / 20 °C
4: H2SO4 / 100 °C
5: 94 percent / Fe; H2O; HCl / ethanol / 16 h / 95 °C
6: 96 percent / Ac2O / 4.5 h / Heating
7: 49 percent / ammonia / methanol / 90 h / 160 °C
8: 72 percent / NaOH; H2 / Pd/C / H2O / 20 h / 1758.3 Torr
9: HCl; mCPBA / N,N-dimethyl-acetamide / 0.42 h / 20 °C
View Scheme
2,6-dichloropyridine N-oxide
2587-00-0

2,6-dichloropyridine N-oxide

3-chloro-3-deazaadenine

3-chloro-3-deazaadenine

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1: HNO3; H2SO4 / 160 °C
2: AcOH; Fe / Heating
3: HNO3; H2SO4 / 20 °C
4: H2SO4 / 100 °C
5: 51 percent / Fe / 2 h / Heating
6: aq. NaOH / Heating
7: 96 percent / Ac2O / 4.5 h / Heating
8: 49 percent / ammonia / methanol / 90 h / 160 °C
9: 72 percent / NaOH; H2 / Pd/C / H2O / 20 h / 1758.3 Torr
10: 6.2 percent / HCl; mCPBA / N,N-dimethyl-acetamide / 0.42 h / 20 °C
View Scheme
Multi-step reaction with 9 steps
1: HNO3; H2SO4 / 160 °C
2: AcOH; Fe / Heating
3: HNO3; H2SO4 / 20 °C
4: H2SO4 / 100 °C
5: 94 percent / Fe; H2O; HCl / ethanol / 16 h / 95 °C
6: 96 percent / Ac2O / 4.5 h / Heating
7: 49 percent / ammonia / methanol / 90 h / 160 °C
8: 72 percent / NaOH; H2 / Pd/C / H2O / 20 h / 1758.3 Torr
9: 6.2 percent / HCl; mCPBA / N,N-dimethyl-acetamide / 0.42 h / 20 °C
View Scheme

2587-00-0Relevant articles and documents

The discovery of novel diarylpyri(mi)dine derivatives with high level activity against a wide variety of HIV-1 strains as well as against HIV-2

Lu, Xueyi,Yang, Jiapei,Kang, Dongwei,Gao, Ping,Daelemans, Dirk,De Clercq, Erik,Pannecouque, Christophe,Zhan, Peng,Liu, Xinyong

, p. 2051 - 2060 (2018/03/23)

By means of structure-based molecular hybridization strategy, a series of novel diarylpyri(mi)dine derivatives targeting the entrance channel of HIV-1 reverse transcriptase (RT) were designed, synthesized and evaluated as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs). Encouragingly, all the tested compounds showed good activities against wild-type (WT) HIV-1 (IIIB) with EC50 in the range of 1.36 nM–29 nM, which is much better than those of nevirapine (NVP, EC50 = 125.42 nM) and azidothymidine (AZT, EC50 = 11.36 nM). Remarkably, these compounds also displayed effective activity against the most of the single and double-mutated HIV-1 strains with low EC50 values, which is comparable to the control drugs. Besides, these compounds were also exhibited favorable enzymatic inhibitory activity. Moreover, preliminary structure-activity relationships (SARs) and molecular modeling study were investigated and discussed in detail. Unexpectedly, four diarylpyrimidines yielded moderate anti-HIV-2 activities. To our knowledge, this is rarely reported that diarylpyrimidine-based NNRTIs have potent activity against both HIV-1 and HIV-2 in cell culture.

Green catalyst induction 2,6-dichloro-pyridine-N-oxide synthesis (by machine translation)

-

Paragraph 0019-0020, (2017/04/11)

The invention discloses a production method for 2,6-dichloropyridine-N-oxide. The production method is characterized in that a novel green catalyst (heteropoly acid) is disclosed according to the synergy effect theory, is prepared by performing oxygen atom coordination bridging on heterotoms and polyatoms according to a certain structure, has the advantages of unique acidity, quasi-liquid behaviors, multifunction (acid, oxidation and photocatalysis) and the like, and can be used for controllably synthesizing the 2,6-dichloropyridine-N-oxide, and successfully realizing the high-content and high-yield synthesis and mass production of the 2,6-dichloropyridine-N-oxide. According to the production method, 2,6-dichloropyridine is used as a raw material, and reaction is accelerated by virtue of high efficiency and multifunction of the heteropoly acid; a synthesis method is simple, high in efficiency, environmentally friendly and suitable for industrial production, and the purity and yield of a product can reach more than 98 percent and 85 percent respectively.

Synthesis and evaluation of novel imidazo[4,5-: C] pyridine derivatives as antimycobacterial agents against Mycobacterium tuberculosis

Madaiah, Malavalli,Prashanth, Maralekere K.,Revanasiddappa, Hosakere D.,Veeresh, Bantal

, p. 9194 - 9204 (2016/11/11)

The current study involves the synthesis of novel imidazo[4,5-c]pyridine derivatives (IPD) containing amide/urea/sulfonamide. The synthesized compounds were evaluated for in vitro and in vivo antimycobacterial activities against Mycobacterium tuberculosis. The pharmacological activities were determined by the objective to better understand their structure-activity relationship (SAR) for their in vitro antimycobacterial activity against M. tuberculosis. Some synthesized compounds showed significant activity against M. tuberculosis based on the agar dilution method. Among the forty-one compounds screened, compounds 21, 22 and 23 were found to be the most active compounds against M. tuberculosis. In the in vivo animal model, 21, 22 and 23 decreased the bacterial load in lung and spleen tissues at the dose of 50 mg kg-1 body weight.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2587-00-0